Referred to the House Committee on Energy and Commerce.
Email me when HR 9077 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 9077. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill orders the National Institutes of Health to review existing research on how hormone levels vary in women before they show perimenopausal symptoms, and directs the Health and Human Services Secretary, through the USPSTF, to assess whether hormone tests are useful for diagnosing or managing perimenopause. Within 18 months, both agencies must submit a joint report to key congressional committees outlining what they found, gaps in knowledge, and recommendations for future work. This aims to improve understanding and care for women going through the perimenopausal transition.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 9077
3 free questions a day, no accountSponsors
- Rep. Scholten, Hillary J. [D-MI-3] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 9077 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 9077 freeOr ask your AI assistant about HR 9077 directly:
Add to Claude, ChatGPT or Cursor